The group of investigators from the RIETE Registry showed 5 lectures and 2 oral communications
In early March, Barcelona hosted the 7th International Symposium to be on Women’s Health Issues in Thrombosis and Haemostasis (WHITH), a meeting to show and discuss new findings in women’s health related to venous thromboembolic disease (VTE) and mechanisms related to bleeding.
The group of investigators from the RIETE registry showed 5 lectures and 2 oral communications in which, thanks to data provided by the registry (more than 70.000 patients with VTE to date), the following aspects of women’s health related to VTE were studied:
- Uterine bleeding is frequent in women under anticoagulant therapy, especially if they are young, and apart from VTE, they suffer from cancer, anemia or blood problems.
- After discontinuation of anticoagulant therapy, chances of a new thrombotic episode are slightly higher in women who had a hormonal treatment when compared to those who had other transitory risk factors.
- Evolution of men and women with VTE and lung, colon, pancreas, stomach or blood cancer is similar during anticoagulant therapy.
- Women who undergo an assisted reproduction treatment have more probabilities of developing a pulmonary embolism than women who get naturally pregnant.
During the three days of the WHITH, other studies non-related to RIETE group were also displayed. The following are relevant to be highlighted:
- Medical guidelines do not make any gender distinction, in the recommendations for VTE prophylaxis in patients with cancer. However, women actually need some specific recommendations.
- In postmenopausal women with breast cancer who need a hormonal treatment, it is better to appeal to aromatase inhibitors than tamoxifen as a measure for decreasing VTE risk.
- Low molecular weight heparin is not recommended for preventing placenta complications during pregnancy
- VTE is one of the main mortality causes among pregnant women in the Western World.
- Venous thrombosis is the most frequent VTE manifestation among under age population.
5th anniversary of World Thrombosis Day
To find out how much you know about the VTE we have made a little quiz. Are you ready?
New direct-acting oral anticoagulants (DOACs) can work better than classic oral anticoagulants
As indicated by one of the studies presented during the 14th Venous Thromboembolism Forum
Hospital Ramón y Cajal launches the PE Code
Hospital Ramón y Cajal of Madrid is the first Spanish centre to activate the PE Code
New advances in the relationship between cancer and thrombosis
Advances presented at the second edition of the International RIETE Meeting
The inferior vena cava filter reduces the risk of pulmonary embolism
The vena cava filter is useful and effective in preventing pulmonary embolism, although it slightly increases the risk of thrombosis.